This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by QUABBE, H.-J. Articles by SCHWARZ, C. Search for Related Content PubMed PubMed Citation Articles by QUABBE, H.-J. Articles by SCHWARZ, C.

Growth Hormone, Cortisol, and Glucagon Concentrations during Plasma Free Fatty Acid Depression: Different Effects of Nicotinic Acid and an Adenosine Derivative (BM 11.189)^*

HANS-JÜRGEN QUABBE, ALFRED S. LUYCKX, MANFRED L’AGE and CORNELIUS SCHWARZ

Section of Endocrinology, Department of Internal Medicine (H.-J.Q.), Klinikum Steglitz, Freie Universität Berlin, West Germany
Secteur de Pharmacologie Clinique (A.S.L.), Institut de Médicine, Départment de Clinique et de Pathologie Médicales, Université de Liége, Belgium

Address requests for reprints to: Dr. H.-J. Quabbe, Medizinische Klinik, Endokrinologische Abteilung, Universitätsklinikum Steglitz, Hindenburgdamm 30, D 1000 Berlin 45, West Germany.

Two chemically unrelated inhibitors of lipolysis were used in order to differentiate between the effect of FFA depression and a possible FFA-unrelated drug effect, respectively, on the plasma concentrations of GH, cortisol, and glucagon. Saline infusion served as a control experiment.

In eight healthy male volunteers, a similar FFA depression by either iv infusion of nicotinic acid (3-pyridine-carboxylic acid, NA) or oral intake of an adenosine derivative, N(6)-allyl-N(6)-cyclohexyl-adenosine (AD-D), was followed by a significant GH increase (to 22.1 ± 6.2 and 9.6 ± 2.9 ng/ml at 240 and 270 min, respectively). Due to the large scatter of the GH concentrations during NA infusion, these responses were not significantly different. No GH increase occurred when the FFA depression was prevented by addition of a lipid infusion.

In contrast, plasma cortisol and glucagon both increasedsignificantly (by 107.4 µg/liter at 270 min and by 48.4 pg/ml at 60 min, respectively) during NA- but not during AD-D-induced FFA depression. Addition of the lipid infusion abolished the cortisol increase during NA infusion but had no influence on basal cortisol concentrations during AD-D intake. It lowered glucagon to values slightly below basal concentrations when added to the NA infusion and more markedly during AD-D administration.

The results provide evidence that 1) depression of plasma FFA per se stimulates the secretion of GH, and 2) the increase of cortisol and glucagon during NA infusion is probably unrelated to the FFA depression. Hence, the stimulatory effect of FFA lack on glucagon secretion needs to be reconsidered.

^* Supported by Deutsche Forschungsgemeinschaft.

Present address: Augusta-Viktoria Krankenhaus, II. Innere Abteilung, Berlin, West Germany.

Received December 22, 1982.

This article has been cited by other articles:

				L. CASHIN-HEMPHILL, C. A. SPENCER, J. T. NICOLOFF, D. H. BLANKENHORN, S. A. NESSIM, H. P. CHIN, and N. A. LEE Alterations in Serum Thyroid Hormonal Indices with Colestipol-Niacin Therapy Ann Intern Med, September 1, 1987; 107(3): 324 - 329. [Abstract] [PDF]